
A good place to live and to study cancer
After completing my postdoctoral training at the University of California, San Diego, I received an attractive offer to work in San Antonio. I am now an associate professor in the molecular medicine department at the University of Texas Health Science Center at San Antonio.

Dynamic control of enhancer repertoires drives stage-specific transcription during tissue development and disease progression. My lab’s overall objective is to gain a fundamental understanding of the regulations of enhancer dynamics in response to signaling and their effects on gene regulation, leading to innovative approaches to prevent and treat enhancer-related diseases, especially cancers.
I wanted to work in this city for several reasons. First, Texas offers substantial start-up funding for researchers across various disciplines to study cancer. As a new PI who recently concluded postdoctoral training and was recruited as a tenure-track faculty member, I received a $2 million start-up grant from the Cancer Prevention and Research Institute of Texas, known as CPRIT. Also, San Antonio is a military city and many people choose to stay after retiring. This ensures abundant clinical resources for researching aging and cancer.
San Antonio also has historical significance and is a vibrant tourist destination, with attractions such as the River Walk and the Alamo. As the seventh-largest city in the U.S., San Antonio offers the advantages of a major urban center while providing a high quality of life due to its affordability and favorable traffic conditions.
My wife is also a PI, researching neuronal diseases. She and I have been immensely content working and living in San Antonio since we moved here from San Diego. Our two young daughters find a lot of fun things to do in this city. Besides working hard in the lab, we often take our daughters out to eat good food, visit the attractions and play at the SeaWorld or Six Flags amusement parks on weekends.
Submit an abstract
, the annual meeting of the 91Ó°¿â and Molecular Biology, will be held March 23–26 in San Antonio. Abstracts for poster presentations and spotlight talks will be accepted through Nov. 30.
Enjoy reading 91Ó°¿âToday?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from 91Ó°¿âToday
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

In memoriam: Norman Meadow
He was a professor of biochemistry at Johns Hopkins University, who studied the bacterial phosphotransferase system and was an 91Ó°¿âmember for more than 30 years.

Meet Lan Huang
Molecular & Cellular Proteomics associate editor uses crosslinking mass spec to study protein–protein interactions to find novel therapeutics.

Meet Shannon Reilly
The JLR junior associate editor discusses the role of adipocytes in obesity at Weill Cornell Medical School.

Meet Donita Brady
Donita Brady is an associate professor of cancer biology and an associate editor of the Journal of Biological Chemistry, who studies metalloallostery in cancer.

Glyco get-together exploring health and disease
Meet the co-chairs of the 2025 91Ó°¿âmeeting on O-GlcNAcylation to be held July 10–13, 2025, in Durham, North Carolina. Learn about the latest in the field and meet families affected by diseases associated with this pathway.

91Ó°¿ârecognizes 2025 outstanding student chapter
The Purdue group, led by Orla Hart, developed STEM outreach initiatives for low-income and minority students in Lafayette, Indiana.